E 200
Pill imprint E 200 has been identified as Morphine sulfate extended-release 200 mg.
Morphine is used in the treatment of pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy.
Morphine 200 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
See also related documents.
Morphine sulfate extended-release Images
- Imprint:
-
E
200 - Strength:
- 200 mg
- Color:
- Brown
- Size:
- 12.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Manufacturer:
- Ethex Corporation
- National Drug Code (NDC):
- 58177-0380
Advertisement
More Morphine Sulfate Extended-Release resources
- Morphine
- Morphine Concentrate (Wolters Kluwer)
- Morphine Extended-Release Capsules (Wolters Kluwer)
- Morphine Immediate-Release (Wolters Kluwer)
- Morphine Immediate-Release Tablets (Wolters Kluwer)
- Morphine Soluble Tablets (Wolters Kluwer)
- Morphine Solution (Wolters Kluwer)
- Morphine Suppositories (Wolters Kluwer)
- Morphine Sustained-Release Tablets (Wolters Kluwer)
- Morphine IR (Cerner Multum)
- morphine (Cerner Multum)
- DepoDur (Micromedex) - Includes Dosage Information
- morphine (Micromedex) - Includes Dosage Information
- morphine Epidural (Micromedex) - Includes Dosage Information
- morphine Injection (Micromedex) - Includes Dosage Information
- Morphine Sulfate (AHFS DI)
- Morphine ER (FDA)
- Morphine Extended Release Capsules (FDA)
- Morphine Injection (FDA)
- Morphine Injection PF (FDA)
- Morphine Oral Solution (FDA)
- Morphine Sulfate (FDA)
- Morphine Sulfate Injection (FDA)
- Morphine Sulfate Solution, Concentrate (FDA)
- Opium Tincture (FDA)
- Morphine Sulfate (Wolters Kluwer)
Search Again
